Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimopoulos

Showing results (141-150 of 3,501) with videos related to

Pageof 351
Sort By:
Expert Review of Anticancer Therapy|December 13, 2005
Neoadjuvant chemotherapy in invasive bladder cancerAristotle Bamias, Meletios A Dimopoulos
The Lancet. Oncology|February 13, 2018
Denosumab for myeloma bone disease: ready for prime time?Meletios A Dimopoulos, Efstathios Kastritis
Blood|September 19, 2019
How I treat Waldenström macroglobulinemiaMeletios A Dimopoulos, Efstathios Kastritis
Leukemia & Lymphoma|July 4, 2018
Managing myeloma with limited resources in the era of novel drugsMeletios A Dimopoulos, Efstathios Kastritis
Seminars in Hematology|April 25, 2009
Multiple myeloma in the era of novel agentsMeletios A Dimopoulos, Michel Attal
Strahlentherapie|February 1, 1972
[Comparative evaluation of treatment results in laryngeal and hypopharyngeal carcinomas]J Dimopoulos, K H Kärcher
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Advances in the treatment of multiple myelomaMeletios A Dimopoulos, Evangelos Terpos
Leukemia & Lymphoma|September 27, 2014
Appraising myc involvement in high risk myelomaEfstathios Kastritis, Meletios A Dimopoulos
BMJ (Clinical Research Ed.)|November 26, 2015
Folic acid fortification for Europe?James L Mills, Aggeliki Dimopoulos
Blood Advances|January 4, 2018
Disease control should be the goal of therapy for WM patientsEfstathios Kastritis, Meletios A Dimopoulos
Pageof 351

Showing results (141-150 of 3,501) with videos related to

Sort By:
Pageof 351
Expert Review of Anticancer Therapy|December 13, 2005
Neoadjuvant chemotherapy in invasive bladder cancerAristotle Bamias, Meletios A Dimopoulos
The Lancet. Oncology|February 13, 2018
Denosumab for myeloma bone disease: ready for prime time?Meletios A Dimopoulos, Efstathios Kastritis
Blood|September 19, 2019
How I treat Waldenström macroglobulinemiaMeletios A Dimopoulos, Efstathios Kastritis
Leukemia & Lymphoma|July 4, 2018
Managing myeloma with limited resources in the era of novel drugsMeletios A Dimopoulos, Efstathios Kastritis
Seminars in Hematology|April 25, 2009
Multiple myeloma in the era of novel agentsMeletios A Dimopoulos, Michel Attal
Strahlentherapie|February 1, 1972
[Comparative evaluation of treatment results in laryngeal and hypopharyngeal carcinomas]J Dimopoulos, K H Kärcher
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Advances in the treatment of multiple myelomaMeletios A Dimopoulos, Evangelos Terpos
Leukemia & Lymphoma|September 27, 2014
Appraising myc involvement in high risk myelomaEfstathios Kastritis, Meletios A Dimopoulos
BMJ (Clinical Research Ed.)|November 26, 2015
Folic acid fortification for Europe?James L Mills, Aggeliki Dimopoulos
Blood Advances|January 4, 2018
Disease control should be the goal of therapy for WM patientsEfstathios Kastritis, Meletios A Dimopoulos
Pageof 351